Author:
Chen Pei-Hsing,Kuo Shuenn-Wen,Chen Jin-Shing
Publisher
Springer Science and Business Media LLC
Reference5 articles.
1. Rusthoven KE, Hammerman SF, Kavanagh BD, Birtwhistle MJ, Stares M, Camidge DR. Is there a role for consolidative stereotactic body radiation therapy following first-line systemic therapy for metastatic lung cancer? A patterns-of-failure analysis Acta Oncol. 2009;48:578–83.
2. Elamin YY, Gomez DR, Antonoff MB, et al. Local consolidation therapy (LCT) after first line tyrosine kinase inhibitor (TKI) for patients with EGFR mutant metastatic non-small-cell lung cancer (NSCLC). Clin Lung Cancer. 2019;20:43–7.
3. Fu F, Wen Z, Gao Z, et al. Primary tumor resection improves survival for EGFR-TKI-treated patients with occult M1a lung adenocarcinoma. Front Oncol. 2021;11:622723–622723.
4. Tseng JS, Hsu KH, Zheng ZR, et al. Primary tumor resection is associated with a better outcome among advanced EGFR-mutant lung adenocarcinoma patients receiving EGFR-TKI treatment. Oncology. 2020;99:32–40.
5. Kuo SW, Chen PH, Lu TP, et al. Primary tumor resection for stage IV non-small-cell lung cancer without progression after first-line epidermal growth factor receptor-tyrosine kinase inhibitor treatment: a retrospective case–control study. Ann Surg Oncol. 2022. https://doi.org/10.1245/s10434-022-11483-7.